Amgen is seeking a Director of Information Systems (IS) Operations and Project Delivery to be based at our corporate campus in Thousand Oaks, CA. The Director will report to the VP, Chief Information Officer.
The Director of Information Systems Operations and Project Delivery will develop and implement an effective technology project management approach across the IS/GBS (Global Business Systems) Technology groups that delivers greater business value, speed, agility and cost efficiencies. Initially, the Director will lead the Project Delivery workstream under Amgen’s “Maximize IS Value” initiative to establish the best practices for delivering these technology projects. Once these best-practices have been established, the Director will transition to become the business owner for maintaining and improving these best practices.
Additionally, the Director will drive the transformation to equip Project Managers (PMs) to better identify and execute portions of our portfolio through product release mindset. Utilizing concepts such as minimal viable product releases iterations (i.e. Pivotal labs), the Director will work cross functionally with ISLT leadership to ensure alignment on global release strategies. Further, the Director will establish and drive adoption of key IS operations’ play book, processes and constructs surrounding IS/GBS operating model.
Key Responsibilities for the Director will include:
Lead Project Delivery workstream as part of Maximize IS Value initiative:
As the Project Delivery Business Owner:
As the Operating Model Business Owner:
Basic Qualifications:
Doctorate degree and 4 years of Information Systems experience
OR
Master’s degree and 8 years of Information Systems experience
OR
Bachelor’s degree and 10 years of Information Systems experience
AND
4 years of managerial experience directly managing people and/or leadership experience leading teams, projects, programs or directing the allocation of resources
Preferred Qualifications:
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.